Adamis Pharmaceuticals Corporation
4 clinical trials · Sponsor
◉ Watch Adamis Pharmaceuticals Corporation
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients. (NCT04729595) | Adamis Pharmaceuticals Corporation | 2021-09-01 |
| Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma (NCT03835871) | Adamis Pharmaceuticals Corporation | 2019-02-01 |
| Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma (NCT03834012) | Adamis Pharmaceuticals Corporation | 2019-02-01 |
Track Adamis Pharmaceuticals Corporation automatically
Every clearance here is in the API, with alerts when new ones post.